The tau-PET tracer [18F]PI-2620 binds to 4R tau and shows increased uptake in PSP-associated regions (e.g., globus pallidus), and is therefore a candidate 4R tau biomarker. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.